Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 390.91K | ||||||
| Operating revenue | ---- | ---- | ---- | --390.91K | ---- | ---- | ---- |
| Cost of revenue | |||||||
| Gross profit | 390.91K | ||||||
| Operating expense | 18.94%2.49M | 33.07%2.09M | -60.30%1.57M | 15.53%3.96M | 5.89%3.42M | -28.07%3.23M | 4.5M |
| Selling and administrative expenses | 19.68%1.91M | -9.54%1.6M | -47.73%1.77M | 13.34%3.38M | 16.22%2.98M | -19.34%2.57M | --3.18M |
| -Selling and marketing expense | -13.43%117.35K | 4.57%135.56K | 86.42%129.64K | 36.75%69.54K | -33.55%50.85K | -64.98%76.52K | --218.53K |
| -General and administrative expense | 22.74%1.8M | -10.65%1.46M | -50.55%1.64M | 12.94%3.31M | 17.75%2.93M | -15.98%2.49M | --2.96M |
| Research and development costs | ---- | ---- | ---- | ---- | --6.55K | ---- | ---- |
| Depreciation amortization depletion | 786.36%312.37K | 16.70%35.24K | -92.07%30.2K | 178.48%380.88K | -60.02%136.77K | 916.33%342.08K | --33.66K |
| -Depreciation and amortization | 786.36%312.37K | 16.70%35.24K | -92.07%30.2K | 178.48%380.88K | -60.02%136.77K | 916.33%342.08K | --33.66K |
| Other operating expenses | -42.96%260.1K | 301.07%455.97K | -216.89%-226.77K | -34.86%194K | -8.37%297.84K | -74.61%325.03K | --1.28M |
| Operating profit | -18.94%-2.49M | -33.07%-2.09M | 55.95%-1.57M | -4.11%-3.56M | -5.89%-3.42M | 28.07%-3.23M | -4.5M |
| Net non-operating interest income (expenses) | -130.19%-24.64K | -137.86%-10.7K | 110.96%28.27K | -202.03%-258K | -272.07%-85.42K | -69.74%49.64K | 164.04K |
| Non-operating interest income | 79.78%53.62K | 1.83%29.83K | 54.15%29.29K | 0.92%19K | -76.23%18.83K | -66.80%79.2K | --238.55K |
| Non-operating interest expense | 93.09%78.26K | 3,865.66%40.53K | -99.63%1.02K | 165.71%277K | 252.73%104.25K | -60.33%29.56K | --74.51K |
| Other net income (expenses) | -104.85%-830.43K | -40.08%-405.38K | -111.80%-289.39K | 199.49%2.45M | -842.89%-2.47M | 450.59%331.86K | 60.27K |
| Special income (charges) | ---- | --6.98K | ---- | 65.99%-997.52K | ---2.93M | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | -65.99%997.52K | --2.93M | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | --6.98K | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | -181.06%-69.79K | -97.50%86.1K | 637.69%3.45M | 40.94%467.73K | 450.59%331.86K | --60.27K |
| Income before tax | -33.31%-3.34M | -36.82%-2.51M | -33.74%-1.83M | 77.08%-1.37M | -109.50%-5.97M | 33.23%-2.85M | -4.27M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | |||||||
| Net income | -33.31%-3.34M | -36.82%-2.51M | -33.74%-1.83M | 77.08%-1.37M | -109.50%-5.97M | 33.23%-2.85M | -4.27M |
| Net income continuous operations | -33.31%-3.34M | -36.82%-2.51M | -33.74%-1.83M | 77.08%-1.37M | -109.50%-5.97M | 33.23%-2.85M | ---4.27M |
| Noncontrolling interests | |||||||
| Net income attributable to the company | -33.31%-3.34M | -36.82%-2.51M | -33.74%-1.83M | 77.08%-1.37M | -109.50%-5.97M | 33.23%-2.85M | -4.27M |
| Preferred stock dividends | |||||||
| Other under preferred stock dividend | |||||||
| Net income attributable to common stockholders | -33.31%-3.34M | -36.82%-2.51M | -33.74%-1.83M | 77.08%-1.37M | -109.50%-5.97M | 33.23%-2.85M | -4.27M |
| Diluted earnings per share | -14.95%-0.0123 | -21.63%-0.0107 | -33.84%-0.0088 | 78.14%-0.0066 | -88.48%-0.0301 | 36.05%-0.016 | -0.0249 |
| Basic earnings per share | -14.95%-0.0123 | -21.63%-0.0107 | -33.84%-0.0088 | 78.14%-0.0066 | -88.48%-0.0301 | 36.05%-0.016 | -0.0249 |
| Dividend per share | |||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |